Patents

CNC invests in the protection of the technologies developed at the institute by generating Intellectual Property (IP) in form of patents. These patents enable the transferring of the knowledge developed in our laboratories to the benefit of the general and scientific community, creating at the same time value to our institute and the local industry.

CNC is the owner of patents in areas such as drug delivery, therapies for brain diseases, biomaterials, cell reprogramming, diagnostic and follow-up strategies, cosmetics, biosynthesis, and animal accommodation for drug production.

If you are interested in our patents for collaboration or licencing purposes, contact the CNC Technology Transfer Office (CNC TechTransfer).

Patents

We use cookies to improve your visit to our website.